A

Annovis Bio
D

ANVS

2.21100
USD
-0.01
(-0.41%)
مغلق
حجم التداول
2,315
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
43,084,057
أصول ذات صلة الأخبار المقالات

العنوان: Annovis Bio

القطاع: Healthcare
الصناعة: Biotechnology
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the companyconsists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.